ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities.

May 31, 2002

Research Triangles Lands Plant Drug Contract Renewal

April 9, 1976

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

May 27, 2005

Breast Density Does Not Raise Breast Cancer Death Rates

August 31, 2012

STAR Begins: Critics of Trial Call For Including A Placebo Arm

June 4, 1999

Nurses Pass Resolution To Support Research on Ethnic Patient Issues

May 29, 1992